Skip to Content

FDA halts use of antibody drugs that don’t work vs. omicron

KIFI

By MATTHEW PERRONE
AP Health Writer

WASHINGTON (AP) — U.S. health officials say COVID-19 antibody drugs from Regeneron and Eli Lilly should no longer be used because they don’t work against the omicron variant. The Food and Drug Administration said Monday it is revoking emergency authorization for both drugs. If they prove effective against future variants, the FDA says it can reauthorize their use. The move was expected because both drugmakers had previously said their drugs are less effective against omicron. Still, the federal action could trigger pushback from some Republican governors who have continued promoting the drugs against the advice of health experts.

Article Topic Follows: AP National Business

Jump to comments ↓

Author Profile Photo

Associated Press

BE PART OF THE CONVERSATION

KIFI Local News 8 is committed to providing a forum for civil and constructive conversation.

Please keep your comments respectful and relevant. You can review our Community Guidelines by clicking here

If you would like to share a story idea, please submit it here.

Skip to content